跳至主要内容
临床试验/NCT05314140
NCT05314140撤回不适用

Towards Optimal Screening and Management of Coronary Artery Disease in Diabetes: TOSCANA Study

French Cardiology Society9 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2025年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
发起方
入组人数
2,000
试验地点
9
主要终点
Proportions of diabetic patients with high coronary artery calcium score

研究概览

简要总结

There are currently only few data on the coronary artery calcium score in patient with diabetes in France, and the diagnostic and therapeutic attitudes towards a high coronary artery calcium score are not standardized and depend on clinical practices, which may vary from one center to another. The proposed multicenter prospective study would provide a better understanding of the epidemiological particularities of the coronary artery calcium score in French diabetics, refine the indications for better performance of the examination, and compare attitudes when this score is high.

详细描述

The prevalence of coronary heart disease in patient with diabetes varies according to the patient's age, the duration of the diabetes, the coexistence of other heart disease risk factors, but also the type of diagnostic used to detect it. In addition, clinical symptoms are often lacking in diabetic patients.

The latest recommendations from the European Society of Cardiology in 2018 propose a graduation of cardiovascular risk into 3 categories according to the presence of cardiovascular disease, other target organ damage, the duration of diabetes and the coexistence of other heart disease risk factors.

The use of imaging can be considered to refine the cardiovascular risk stratification , such as detection of carotid plaque (class IIa), coronary artery calcium score (class IIb) or even the coronary scanner or ischemia tests (class IIb ). In a much more pragmatic and operational way, the French Society of Cardiology and the Francophone Society of Diabetology very recently published a consensus document, proposing a cardiovascular risk stratification based on clinical elements, the existence of other cardiovascular risk factors and target organ damage risk factors, and the use of the coronary artery calcium score to stratify in particular patients qualified as high risk.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Coronary asymptomatic patient
  • Patient with type 2 diabetes and aged 50 to 70 or - Patient with type 2 diabetes for more than 10 years and aged 18 to 50 or - Patient with type 1 diabetes for more than 20 years and aged > 35
  • Coronary artery calcium score evaluation planned

排除标准

  • Patients who already have a clinical history of coronary disease
  • Patients with other peripheral arterial disease
  • Patients with clinical suspicion of coronary artery disease
  • Patients with progressive cancer
  • Patients with serious chronic conditions with an estimated life expectancy < 3 years.
  • Pregnant, lactating, or pre-menopausal women without a recent negative pregnancy test available.
  • Patients under guardianship or curator or placed under justice safeguard
  • Patients who do not benefit from the social security scheme, or any equivalent scheme
  • Patients refusing or being linguistically or psychologically unable to sign the informed consent form
  • Participation in another biomedical research protocol is permitted

研究组 & 干预措施

Coronary artery calcium score evaluation

Patients with diabetes and having a CT scan for evaluation of their coronary artery calcium score will be consecutively include. The indication of the scanner is at the choice of the clinician (usually cardiologist and/or diabetologist), in compliance with the recommendations

干预措施: Coronary artery calcium score evaluation (Diagnostic Test)

结局指标

主要结局

Proportions of diabetic patients with high coronary artery calcium score

时间窗: day 1

Number of patient with diabetes having a coronary artery calcium score higher than 400

次要结局

  • Proportion of patients having a coronary exploration(6 months)
  • Proportion of patients having a myocardial revascularization(3 months)
  • Description of adverse events regarding to the coronary artery calcium score(6 months / 12 months / 18 months / 24 months / 30 months / 36 months / 42 months / 48 months)

研究者

发起方
French Cardiology Society
申办方类型
Other
责任方
Sponsor

研究点 (9)

Loading locations...

相似试验